Accession Number: | 0001209191-20-004150 |
Date: | 2020-01-16 |
Issuer: | SPECTRUM PHARMACEUTICALS INC (SPPI) |
Original Submission Date: |
TURGEON JOSEPH W.
11500 S. EASTERN AVENUE
SUITE 240
HENDERSON, NV 89052
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.001 PAR VALUE | 2020-01-16 | S | 3,753 | d | $3.37 | 427,224 | direct | ||
COMMON STOCK, $0.001 PAR VALUE | 2020-01-17 | S | 1,944 | d | $3.33 | 425,280 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | all sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer. |